vs
Side-by-side financial comparison of Peraso Inc. (PRSO) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.
cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $2.9M, roughly 1.7× Peraso Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -43.3%, a 37.7% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -22.0%). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs 1.0%).
Peraso Inc. is a semiconductor technology firm specializing in the design and production of high-performance millimeter wave (mmWave) integrated circuits and modules. It delivers 5G and next-generation wireless connectivity solutions for telecom infrastructure, industrial IoT, fixed wireless access and consumer electronics segments, serving customers across North America, Asia Pacific and European markets.
cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.
PRSO vs YCBD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $5.0M |
| Net Profit | $-1.2M | $-283.1K |
| Gross Margin | 52.2% | 59.8% |
| Operating Margin | -44.6% | -5.7% |
| Net Margin | -43.3% | -5.6% |
| Revenue YoY | -22.0% | -1.9% |
| Net Profit YoY | 20.3% | -1975.7% |
| EPS (diluted) | $-0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | $5.0M | ||
| Q3 25 | $3.2M | $4.7M | ||
| Q2 25 | $2.2M | $4.6M | ||
| Q1 25 | $3.9M | $4.7M | ||
| Q4 24 | $3.7M | $5.1M | ||
| Q3 24 | $3.8M | $4.6M | ||
| Q2 24 | $4.2M | $5.2M | ||
| Q1 24 | $2.8M | $4.4M |
| Q4 25 | $-1.2M | $-283.1K | ||
| Q3 25 | $-1.2M | $-680.0K | ||
| Q2 25 | $-1.8M | $-895.3K | ||
| Q1 25 | $-471.0K | $-480.8K | ||
| Q4 24 | $-1.6M | $15.1K | ||
| Q3 24 | $-2.7M | $-152.8K | ||
| Q2 24 | $-4.4M | $459.7K | ||
| Q1 24 | $-2.0M | $-3.0M |
| Q4 25 | 52.2% | 59.8% | ||
| Q3 25 | 56.2% | 58.8% | ||
| Q2 25 | 48.3% | 61.5% | ||
| Q1 25 | 69.3% | 62.3% | ||
| Q4 24 | 56.3% | 66.5% | ||
| Q3 24 | 47.0% | 53.9% | ||
| Q2 24 | 55.5% | 65.8% | ||
| Q1 24 | 46.4% | 59.0% |
| Q4 25 | -44.6% | -5.7% | ||
| Q3 25 | -36.8% | -14.5% | ||
| Q2 25 | -80.0% | -19.6% | ||
| Q1 25 | -13.3% | -10.2% | ||
| Q4 24 | -44.3% | -1.7% | ||
| Q3 24 | -70.3% | -6.9% | ||
| Q2 24 | -105.6% | -7.4% | ||
| Q1 24 | -128.9% | -35.4% |
| Q4 25 | -43.3% | -5.6% | ||
| Q3 25 | -37.4% | -14.4% | ||
| Q2 25 | -82.4% | -19.4% | ||
| Q1 25 | -12.2% | -10.1% | ||
| Q4 24 | -42.4% | 0.3% | ||
| Q3 24 | -70.6% | -3.4% | ||
| Q2 24 | -104.4% | 8.9% | ||
| Q1 24 | -72.1% | -68.8% |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $-0.31 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $-0.98 | — | ||
| Q2 24 | $-1.88 | $-0.15 | ||
| Q1 24 | $-1.07 | $-1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.9M | $3.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.6M | $9.0M |
| Total Assets | $6.1M | $11.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9M | $3.4M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | $3.3M | $2.0M | ||
| Q3 24 | $1.3M | $2.5M | ||
| Q2 24 | $1.9M | $2.4M | ||
| Q1 24 | $2.4M | $2.1M |
| Q4 25 | $4.6M | $9.0M | ||
| Q3 25 | $3.6M | $7.2M | ||
| Q2 25 | $3.0M | $6.1M | ||
| Q1 25 | $3.6M | $665.8K | ||
| Q4 24 | $3.5M | $1.8M | ||
| Q3 24 | $2.0M | $2.0M | ||
| Q2 24 | $3.6M | $3.0M | ||
| Q1 24 | $6.7M | $3.1M |
| Q4 25 | $6.1M | $11.8M | ||
| Q3 25 | $6.2M | $10.4M | ||
| Q2 25 | $5.5M | $9.9M | ||
| Q1 25 | $6.7M | $10.9M | ||
| Q4 24 | $7.2M | $11.5M | ||
| Q3 24 | $7.2M | $10.6M | ||
| Q2 24 | $9.8M | $13.8M | ||
| Q1 24 | $11.5M | $14.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-812.5K |
| Free Cash FlowOCF − Capex | — | $-977.3K |
| FCF MarginFCF / Revenue | — | -19.5% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $-812.5K | ||
| Q3 25 | $-1.5M | $-240.7K | ||
| Q2 25 | $-2.0M | $-704.2K | ||
| Q1 25 | $-966.0K | $-189.5K | ||
| Q4 24 | $-687.0K | $-317.9K | ||
| Q3 24 | $-683.0K | $167.4K | ||
| Q2 24 | $-659.0K | $289.8K | ||
| Q1 24 | $-2.5M | $-704.1K |
| Q4 25 | — | $-977.3K | ||
| Q3 25 | $-1.6M | $-243.6K | ||
| Q2 25 | — | $-705.7K | ||
| Q1 25 | — | $-205.0K | ||
| Q4 24 | — | $-482.3K | ||
| Q3 24 | — | $157.4K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-708.7K |
| Q4 25 | — | -19.5% | ||
| Q3 25 | -48.9% | -5.2% | ||
| Q2 25 | — | -15.3% | ||
| Q1 25 | — | -4.3% | ||
| Q4 24 | — | -9.4% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -16.2% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -21.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRSO
| Products | $2.8M | 96% |
| Other | $105.0K | 4% |
YCBD
| Sales Channel Directly To Consumer | $3.6M | 72% |
| Sales Channel Through Intermediary | $1.4M | 28% |
